Profiel
Dganit Bar worked as an Executive Director-Science & Technology at BioLineRx Ltd. from 2004 to 2012.
Prior to that, she was the Head-Cancer Research at QBI Enterprises Ltd. from 2000 to 2004.
From 2012 to 2017, she served as the Chief Scientific Officer at Rosetta Genomics Ltd. Dr. Bar completed her undergraduate degree at The Hebrew University of Jerusalem and her graduate and doctorate degrees at Ben-Gurion University of the Negev.
Eerdere bekende functies van Dganit Bar
| Bedrijven | Functie | Einde |
|---|---|---|
| ROSETTA GENOMICS LTD. | Hoofd Techniek/Wetenschap/O&O | 14-03-2017 |
| BIOLINERX LTD. | Hoofd Techniek/Wetenschap/O&O | 01-01-2012 |
QBI Enterprises Ltd.
QBI Enterprises Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutics | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Dganit Bar
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Rosetta Genomics Ltd.
Rosetta Genomics Ltd. BiotechnologyHealth Technology Provides therapeutic, diagnostic product development and medical research services | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
QBI Enterprises Ltd.
QBI Enterprises Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutics | Health Technology |
















